Jefferies Keeps $2,600 Target on MercadoLibre Despite Margin Shifts

Jefferies has reiterated its Buy rating and $2,600 price target on MercadoLibre (MELI). The firm expects the company's expansion into drug retail to outweigh recent pressure on operating margins. Although investors have scrutinized the contraction in profitability, analysts maintain that the e-commerce company's growth trajectory remains intact.

"MercadoLibre's expansion into first-party and third-party drug retail is expected to drive frequency, recurrence, and conversion," according to a Jefferies research note.

Financial Performance and Margin Contraction

MercadoLibre’s latest financial results show a tension between top-line expansion and operational costs. In Q2 2026, the company reported revenue exceeding $10 billion, a 50% increase compared to the same period in 2025. Earnings for the quarter reached $9.19 per share.

This growth has impacted profitability margins. According to data reported by Ad Hoc News, the operating margin fell to 6.7% in Q2 2026, down from 12.2% in Q2 2025. This decline is attributed to capital allocation toward shipping infrastructure, credit services, and customer acquisition.

Why Drug Retail Matters

The move into the pharmaceutical sector is central to the outlook from Jefferies. By integrating drug retail through first-party inventory and third-party marketplace listings, MercadoLibre aims to increase the frequency of platform visits. Analysts suggest that by capturing a higher share of essential consumer purchases, the company can improve conversion rates and reduce the long-term cost of customer acquisition.

What Is at Stake for Investors

The market focus on EBIT margin dilution reflects a debate regarding whether the high-growth phase of MercadoLibre justifies current investment levels. As the company scales its fintech and logistics arms alongside new retail verticals, the ability to balance these capital-intensive projects with free cash flow remains a primary metric for institutional investors. The reiteration from Jefferies suggests the firm views the current margin compression as a trade-off for capturing market share in high-frequency categories.